Vendor Neutral Archive (VNA) & PACS Market

Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends by Product Type (Department, Multi-Department, Multi-Site), Modality (CT, MRI, X-rays, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag Center) & Region - Global Forecast to 2029

Report Code: HIT 2128 May, 2024, by marketsandmarkets.com

Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends

The size of global Vendor Neutral Archive (VNA) & PACS market in terms of revenue was estimated to be worth $4.6 billion in 2024 and is poised to reach $7.3 billion by 2029, growing at a CAGR of 9.5% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

Growth of the market is mainly driven by increasing volumes of medical imaging data, regulatory mandates for electronic health records (EHRs). Moreover, the shift towards value-based care models, and technological advancements such as cloud storage and AI-driven analytics are further driving adoption of VNA & PACS solution to enhance clinical workflows and improve patient care outcomes.

Vendor Neutral Archive (VNA) & PACS Market Trends

Vendor Neutral Archive (VNA) & PACS  Market

To know about the assumptions considered for the study, Request for Free Sample Report

Vendor Neutral Archive (VNA) & PACS  Market

Global Vendor Neutral Archive (VNA) & PACS Market Dynamics

DRIVER: Growing demand for streamlined healthcare data management solutions

The exponential growth of medical imaging data, propelled by advancements in imaging technology and the digitization of healthcare records, necessitates robust data management solutions. Healthcare providers deal with vast amounts of imaging data, ranging from X-rays and MRIs to CT scans, creating a need for efficient storage, retrieval, and sharing mechanisms. Moreover, the shift towards value-based care models, which prioritize quality outcomes and cost-effectiveness, underscores the importance of data-driven decision-making and coordinated care delivery. VNA and PACS solutions play a pivotal role in enabling healthcare providers to leverage medical imaging data for diagnostic accuracy, treatment planning, and monitoring patient progress. By facilitating efficient data management and analysis, these solutions contribute to improved clinical workflows, reduced diagnostic errors, and enhanced patient outcomes. As the demand for improved patient care and safety continues to rise alongside advancements in healthcare technology, the Vendor Neutral Archive (VNA) & PACS market is expected to experience significant growth in forecasted period.

Restraint: Lack of standardized protocols and interoperability frameworks

The lack of standardized protocols and interoperability frameworks complicates data sharing and collaboration among healthcare providers, hindering the seamless exchange of medical images and patient records. As a result, healthcare professionals encounters interoperability issues while accessing patient data from different systems or transferring images between facilities, leading to inefficiencies in clinical workflows and potentially compromising patient care. Moreover, the high implementation and maintenance costs associated with deploying VNA and PACS systems, including investments in infrastructure, software, and training, restrain the adoption, particularly in resource-constrained healthcare settings. Thus, the ongoing expenses related to system maintenance, upgrades, and cybersecurity measures further add to the financial strain on healthcare institutions.

OPPORTUNITY: Increasing Medical Imaging Procedures and Large Imaging Data Silos

The increase in medical imaging procedures has led to growth opportunities in the VNA and PACS solution market, as healthcare providers seek scalable and efficient solutions to cope with the growing volumes of imaging data. Moreover, these solutions offer healthcare organizations a comprehensive approach to address the complexities of imaging data management as well as a centralized repository for storing medical images and associated metadata in a standardized format, breaking down data silos and enabling seamless interoperability and data exchange across disparate systems and departments. Moreover, the growing adoption of AI and analytics integration within VNA and PACS systems presents growing opportunities for enhanced automated image analysis, predictive analytics, and clinical decision support. This advancement significantly improves diagnostic accuracy and efficiency. Additionally, leveraging natural language processing with VNA and PACS solutions fosters the development of novel applications, further enhancing diagnostic precision and workflow efficiency. As these technologies continue to evolve and demonstrate their value in optimizing healthcare processes, the demand for VNA and PACS solutions is poised to surge, driven by the increasing need for advanced imaging capabilities and improved clinical outcome.

CHALLENGE: Data security issues

Data security remains a paramount concern within the Vendor Neutral Archive (VNA) and Picture Archiving and Communication System (PACS) market, as healthcare organizations grapple with safeguarding sensitive patient information amidst evolving cybersecurity threats. For instance, according to Greenbone Security 2019 Report revealed that the unprotected PACS server accounted for 1.19 billion medical images leaked in span of three months. Such breaches not only compromise patient privacy but also erode trust in healthcare systems and expose organizations to regulatory penalties and legal repercussions. Moreover, data security and privacy concerns remain significant challenges in cloud-based solutions, as healthcare organizations need robust security measures to protect sensitive patient information in the cloud. Thus, the potential security concerns related to HCIT system has the potential to impede the adoption of new technologies potentially limiting the growth of the Vendor Neutral Archive (VNA) & PACS market.

Vendor Neutral Archive (VNA) & PACS Market Ecosystem

The Vendor Neutral Archive (VNA) & PACS market is highly competitive with a large number of intermediaries involved in the market. The market includes the VNA and PACS vendors, ranging from large enterprises to niche players, that develops and provides innovative solutions for storing and managing medical imaging data. These vendors navigate regulatory frameworks set by government bodies like the FDA, EMA, and Health Canada, ensuring compliance with standards and guidelines related to data security, interoperability, and patient privacy. Moreover, government bodies such as the Department of Health and Human Services (HHS) and the National Health Service (NHS) influence market dynamics through policy decisions, funding initiatives, and regulatory oversight. Meanwhile, end-users, comprising healthcare providers such as hospitals, clinics, and imaging centers, drive demand for VNA and PACS solutions to streamline workflow efficiency, improve diagnostic accuracy, and enhance patient care delivery. This interconnected ecosystem relies on collaboration, innovation, and adherence to regulatory requirements to ensure the seamless integration and effective utilization of VNA and PACS solutions within the healthcare landscape.

Vendor Neutral Archive (VNA) & PACS  Market Ecosystem

Source: Secondary Literature, Interviews with Experts, and MarketsandMarkets Analysis

The global Vendor Neutral Archive (VNA) & PACS Industry is segmented by platform, component, deployment mode, application, end user, and region

By product type, The Vendor Neutral Archive (VNA) segment accounted for the largest share of the VNA & PACS industry in 2023.

By product type, the Vendor Neutral Archive (VNA) & PACS market is segmented into VNA and PACS solution. The Vendor Neutral Archive (VNA) segment accounted for the largest market share in 2023. This segment is further sub segmented into department VNA, multi-department VNA and multi-site VNA solutions. Vendor Neutral Archive solution offers a centralized repository for storing medical images and associated metadata in a standardized format, independent of specific imaging modalities or vendors. This vendor-agnostic approach enables seamless data exchange across disparate systems and healthcare facilities, facilitating collaboration and care coordination among healthcare providers. Moreover, the shift towards value-based care models emphasizes the importance of comprehensive data management solutions like VNA. As healthcare organizations are increasingly leveraging medical imaging data for population health management, predictive analytics, and personalized medicine initiatives these VNA solutions plays a pivotal role in shaping the future of medical imaging and healthcare informatics. In addition, VNA solutions provide the infrastructure needed to aggregate, analyze, and derive insights from large volumes of imaging data, supporting data-driven decision-making, and improving patient outcomes for enhanced quality of care.

The cloud based deployment model is the fastest growing segment in the Vendor Neutral Archive (VNA) & PACS industry.

Based on deployment, the Vendor Neutral Archive (VNA) & PACS market is segmented into on-premises, cloud-based based and hybrid model. The cloud-based Vendor Neutral Archive (VNA) and Picture Archiving and Communication System (PACS) market is poised for significant growth in the forecast period. As these solutions eliminate the need for extensive on-premises infrastructure investments, allowing healthcare providers to scale their storage capacity and computing resources based on demand. In addition, the cloud service providers implement robust security measures, including encryption, access controls, and regular security audits, to safeguard patient information and ensure compliance with industry regulations such as HIPAA (Health Insurance Portability and Accountability Act) and GDPR (General Data Protection Regulation). This scalability enables healthcare organizations to accommodate growing volumes of medical imaging data generated from diagnostic procedures, such as X-rays, MRIs, and CT scans, without the constraints of data hacking and traditional storage infrastructure. Moreover, cost-effectiveness, and ease of remote and real-time monitoring are some of the factors attributing to the growth of the segment.

Hospitals & clinics accounted for the largest share of the Vendor Neutral Archive (VNA) & PACS industry in 2023.

Based on end-users, the Vendor Neutral Archive (VNA) & PACS market is segmented into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end-users which includes research and academic institutes. The hospitals & clinics dominate the end-user segment of the Vendor Neutral Archive (VNA) & PACS market as these healthcare facilities generate vast volumes of medical imaging data daily, necessitating robust solutions for managing, storing, and accessing this data efficiently. Moreover, these solutions provide a centralized repository for storing medical images and associated metadata in a standardized format, enabling seamless access and retrieval of patient information across different departments and facilities within hospitals and clinics. Owing to the increasing demand for personalized, data-driven care, hospitals and clinics segment will remain at the forefront of innovation and investment in VNA and PACS solutions to meet the evolving needs of patients and healthcare professionals alike.

North America accounts the largest share of Vendor Neutral Archive (VNA) & PACS industry in 2023.

Based on the region, the Vendor Neutral Archive (VNA) & PACS market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023 North America accounted for the largest share of the Vendor Neutral Archive (VNA) & PACS market due to its highly developed healthcare infrastructure, strong emphasis on digital transformation and interoperability, robust ecosystem of VNA and PACS vendors, and growing demand for diagnostic imaging services. As North American healthcare organizations continue to prioritize investments in data management solutions and embrace digital innovation, the region is poised to maintain its leadership position in the VNA and PACS market.

Vendor Neutral Archive (VNA) & PACS  Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in Vendor Neutral Archive (VNA) & PACS market include Hyland Software, Inc. (US), Agfa-Gevaert Group. (Belgium), Intelerad Medical Systems Inc (Canada), CANON MEDICAL SYSTEMS CORPORATION (Japan), FUJIFILM Holdings Corporation (Japan), GE HEALTHCARE TECHNOLOGIES INC. (US), Merative (US), Sectra AB (Sweden), Siemens Healthcare Limited (Germany), BridgeHead Software Ltd. (UK), Canopy Partners. (US), Novarad Corporation.(US), POSTDICOM (Netherlands), AdvaHealth Solutions Pte Ltd (Singapore), CrelioHealth (India), Medicasoft. (US), Esaote SPA (Italy), PaxeraHealth (US), VISUS Health IT GmbH (Germany), ASPYRA, LLC (US), Dedalus S.p.A. (Italy), SoftTeam Solutions Pvt Ltd. (India), ARO Systems (Australia), Central Data Networks (Australia), and ONEPACS (US).

Scope of the Vendor Neutral Archive (VNA) & PACS Industry:

Report Metric

Details

Market Revenue in 2024

$4.6 billion

Projected Revenue by 2029

$7.3 billion

Revenue Rate

Poised to Grow at a CAGR of 9.5%

Market Driver

Growing demand for streamlined healthcare data management solutions

Market Opportunity

Increasing Medical Imaging Procedures and Large Imaging Data Silos

The study categorizes the Vendor Neutral Archive (VNA) & PACS Market based on platform, component, deployment, application, end user, at regional and global level.

By Product Type
  • VNA
    • Department VNA
    • Multi-Department VNA
    • Multi-Site VNA
  • PACS
    • Department PACS
    • Multi-Department PACS
    • Multi-Site PACS
By Modality
  • CT
  • Mammography
  • MRI
  • Ultrasound
  • X-Rays
  • PET
By Deployment
  • On-Premise
  • Cloud-Based
  • Hybrid Model
By Vendor Type
  • Independent Vendor
  • Third-party Vendor
By Application
  • Cardiology
  • Orthopedic
  • Oncology
  • Neurology
  • Obstetrics and Gynecology
  • Other (Dental, Respiratory, Urology and Nephrology)
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others (Academic and Research Institutes)
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • Rest of Middle East and Africa

Recent Developments of Vendor Neutral Archive (VNA) & PACS Industry:

  • In January 2024, RamSoft (Canada) launched imaging EMR solution, named OmegaAI. The solution is a cloud-native, serverless imaging EMR software platform that consolidates VNA, Enterprise Imaging, PACS, RIS, simplified image exchange/sharing, routing & storage, a zero-footprint (ZFP) viewer, unified worklist, radiology reporting, document management, peer, patient portal, and a real-time business intelligence and analytics solution.
  • In November 2023, InsiteOne (US) announced to acquire BRIT Systems cloud native RIS/PACS/VNA solution to advance imaging workflows. This acquisition will continue to focus on developing cost-effective solutions that improve operational productivity while enhancing patient care.
  • In November 2022, GE HEALTHCARE TECHNOLOGIES INC. (US) collaborated with Tribun Health (Paris), to offer digital pathology departmental solutions that give healthcare providers a comprehensive perspective of patient records, this collaboration aims to integrate Tribun’s Health Suite data with GE Healthcare’s solutions, including its vendor-neutral archive (VNA) solution portfolio.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION 
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY 
 
4 PREMIUM INSIGHTS (Page No. - 67)
    4.1 OVERVIEW OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 
    4.2 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE AND COUNTRY 
    4.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
    4.4 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL MIX 
    4.5 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEVELOPED VS. EMERGING MARKETS 
 
5 MARKET OVERVIEW (Page No. - 71)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Heightened investments in medical imaging technologies
                    5.2.1.2 Growing demand for streamlined healthcare data management solutions
                    5.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs)
           5.2.2 RESTRAINTS
                    5.2.2.1 High initial investment
                    5.2.2.2 Lack of standardized protocols and interoperability frameworks
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Government initiatives to increase penetration of Al in medical imaging
                    5.2.3.2 Increasing medical imaging procedures and large imaging data silos
                    5.2.3.3 Rapid uptake of big data in healthcare
           5.2.4 CHALLENGES
                    5.2.4.1 Rising security concerns related to cloud-based image processing and analytics
                    5.2.4.2 Data security issues
 
6 INDUSTRY TRENDS (Page No. - 77)
    6.1 CURRENT TRENDS 
           6.1.1 CLOUD ADOPTION
           6.1.2 AI INTEGRATION
           6.1.3 VALUE-BASED CARE FOCUS
    6.2 TECHNOLOGY ANALYSIS 
           6.2.1 KEY TECHNOLOGIES
                    6.2.1.1 DICOM (Digital Imaging and Communications in Medicine)
                    6.2.1.2 Enterprise imaging solutions
                    6.2.1.3 Cloud-based storage and services
           6.2.2 COMPLEMENTARY TECHNOLOGIES
                    6.2.2.1 Image exchange networks
                    6.2.2.2 Data analytics and business intelligence
           6.2.3 ADJACENT TECHNOLOGIES
                    6.2.3.1 Health Information Exchange (HIE)
    6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    6.4 VALUE CHAIN ANALYSIS 
    6.5 ECOSYSTEM MAPPING 
    6.6 PORTER’S FIVE FORCES ANALYSIS 
           6.6.1 INTENSITY OF COMPETITIVE RIVALRY
           6.6.2 BARGAINING POWER OF SUPPLIERS
           6.6.3 BARGAINING POWER OF BUYERS
           6.6.4 THREAT OF NEW ENTRANTS
           6.6.5 THREAT OF SUBSTITUTES
    6.7 KEY CONFERENCES & EVENTS 
    6.8 PRICING ANALYSIS 
           6.8.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
           6.8.2 AVERAGE SELLING PRICE TREND, BY REGION
    6.9 REGULATORY LANDSCAPE 
           6.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.9.2 REGULATIONS
                    6.9.2.1 US
                    6.9.2.2 Europe
                    6.9.2.3 China
                    6.9.2.4 Japan
                    6.9.2.5 India
    6.10 PATENT ANALYSIS 
           6.10.1 PATENT PUBLICATION TRENDS FOR VNA AND PACS
           6.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    6.11 CASE STUDY ANALYSIS 
           6.11.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM
           6.11.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
           6.12.2 BUYING CRITERIA
    6.13 END-USER ANALYSIS 
           6.13.1 UNMET NEEDS
           6.13.2 END-USER EXPECTATIONS
    6.14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BUSINESS MODELS 
           6.14.1 ENTERPRISE LICENSING:
           6.14.2 SOFTWARE-AS-A-SERVICE (SAAS):
           6.14.3 PAY-PER-USE:
           6.14.4 HYBRID MODELS:
 
7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY (Page No. - 95)
    7.1 INTRODUCTION 
    7.2 CT 
           7.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH
    7.3 MAMMOGRAPHY 
           7.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
    7.4 ULTRASOUND 
           7.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH
    7.5 MAGNETIC RESONANCE IMAGING (MRI) 
           7.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET
    7.6 X-RAY 
           7.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET
    7.7 PET 
           7.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET
 
8 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL (Page No. - 109)
    8.1 INTRODUCTION 
    8.2 ON-PREMISES MODEL 
           8.2.1 ON-PREMISES DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA
    8.3 CLOUD-BASED MODEL 
           8.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL’S POPULARITY
    8.4 HYBRID MODEL 
           8.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS
 
9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE (Page No. - 118)
    9.1 INTRODUCTION 
    9.2 VNA 
           9.2.1 DEPARTMENT VNA
                    9.2.1.1 Limitations in addressing scalability and interoperability challenges across diverse departments to hinder market growth
           9.2.2 MULTI-DEPARTMENT VNA
                    9.2.2.1 Trend toward adopting value-based platform solutions to support market growth
           9.2.3 MULTI-SITE VNA
                    9.2.3.1 Need for storage of large medical image data and seamless sharing within and between enterprises to support market growth
    9.3 PACS 
           9.3.1 DEPARTMENT PACS
                    9.3.1.1 Increasing storage of medical imaging data across various applications to support market growth
           9.3.2 MULTI-DEPARTMENT PACS
                    9.3.2.1 Streamlining radiology operations for enhanced image accessibility to support market growth
           9.3.3 MULTI-SITE PACS
                    9.3.3.1 Advancement in cloud-based PACS solutions to propel market growth
 
10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE (Page No. - 138)
     10.1 INTRODUCTION 
     10.2 INDEPENDENT VENDOR 
             10.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE
     10.3 THIRD-PARTY VENDOR 
             10.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS’ PRESENCE IN MARKET
 
11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION (Page No. - 144)
     11.1 INTRODUCTION 
     11.2 CARDIOLOGY 
             11.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET
     11.3 ORTHOPEDIC 
             11.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH
     11.4 ONCOLOGY 
             11.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
     11.5 NEUROLOGY 
             11.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
     11.6 OBSTETRICS & GYNECOLOGY 
             11.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS
     11.7 OTHER APPLICATIONS 
 
12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER (Page No. - 159)
     12.1 INTRODUCTION 
     12.2 HOSPITALS & CLINICS 
             12.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
     12.3 DIAGNOSTIC CENTERS 
             12.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS
     12.4 AMBULATORY SURGERY CENTERS 
             12.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS
     12.5 OTHER END USERS 
 
13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION (Page No. - 169)
     13.1 INTRODUCTION 
     13.2 NORTH AMERICA 
             13.2.1 NORTH AMERICA: RECESSION IMPACT
             13.2.2 US
                        13.2.2.1 Rising incidences of chronic diseases to drive market
             13.2.3 CANADA
                        13.2.3.1 Rising cases of end-stage kidney diseases to propel use of VNA and PACS solutions
     13.3 EUROPE 
             13.3.1 EUROPE: RECESSION IMPACT
             13.3.2 GERMANY
                        13.3.2.1 High number of MRI units to drive market
             13.3.3 UK
                        13.3.3.1 Increasing investments in diagnostic imaging to drive market
             13.3.4 FRANCE
                        13.3.4.1 Rising target patient population and government-funded investments for advanced medical equipment to fuel uptake
             13.3.5 ITALY
                        13.3.5.1 Established healthcare infrastructure to support overall market growth
             13.3.6 SPAIN
                        13.3.6.1 Growing access to advanced cancer diagnostics to propel market
             13.3.7 REST OF EUROPE
     13.4 ASIA PACIFIC 
             13.4.1 ASIA PACIFIC: RECESSION IMPACT
             13.4.2 JAPAN
                        13.4.2.1 Presence of universal healthcare coverage to fuel market
             13.4.3 CHINA
                        13.4.3.1 Strong government support for healthcare reforms and increasing number of medical imaging procedures to drive market
             13.4.4 INDIA
                        13.4.4.1 Improving healthcare infrastructure to support growth of medical image analysis software market
             13.4.5 REST OF ASIA PACIFIC
     13.5 LATIN AMERICA 
             13.5.1 LATIN AMERICA: RECESSION IMPACT
             13.5.2 BRAZIL
                        13.5.2.1 High export of medical devices to propel market
             13.5.3 MEXICO
                        13.5.3.1 Rapid technological advancements in imaging solutions to support market growth
             13.5.4 REST OF LATIN AMERICA
     13.6 MIDDLE EAST & AFRICA 
             13.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS
             13.6.2 GCC COUNTRIES
                        13.6.2.1 Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
             13.6.3 REST OF MIDDLE EAST & AFRICA
 
14 COMPETITIVE LANDSCAPE (Page No. - 334)
     14.1 OVERVIEW 
     14.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 
     14.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 
     14.4 MARKET SHARE ANALYSIS 
     14.5 BRAND/SOFTWARE COMPARATIVE ANALYSIS 
             14.5.1 AGFA-GEVAERT GROUP
             14.5.2 FUJIFILM HOLDINGS CORPORATION
             14.5.3 MERATIVE
             14.5.4 NOVARAD CORPORATION
             14.5.5 PAXERAHEALTH
             14.5.6 ONEPACS
     14.6 COMPANY EVALUATION AND FINANCIAL METRICS 
     14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             14.7.1 STARS
             14.7.2 EMERGING LEADERS
             14.7.3 PERVASIVE PLAYERS
             14.7.4 PARTICIPANTS
             14.7.5 COMPANY FOOTPRINT ANALYSIS
     14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 
             14.8.1 PROGRESSIVE COMPANIES
             14.8.2 RESPONSIVE COMPANIES
             14.8.3 DYNAMIC COMPANIES
             14.8.4 STARTING BLOCKS
             14.8.5 COMPETITIVE BENCHMARKING
     14.9 COMPETITIVE SITUATIONS & TRENDS 
             14.9.1 PRODUCT LAUNCHES & UPGRADES
             14.9.2 DEALS
             14.9.3 OTHER DEVELOPMENTS
 
15 COMPANY PROFILES (Page No. - 354)
     15.1 KEY COMPANIES 
             15.1.1 AGFA-GEVAERT GROUP
                        15.1.1.1 Business overview
                        15.1.1.2 Solutions offered
                        15.1.1.3 Recent developments
                        15.1.1.4 MnM view
                                     15.1.1.4.1 Right to win
                                     15.1.1.4.2 Strategic choices
                                     15.1.1.4.3 Weaknesses & competitive threats
             15.1.2 FUJIFILM HOLDINGS CORPORATION
                        15.1.2.1 Business overview
                        15.1.2.2 Solutions offered
                        15.1.2.3 Recent developments
                        15.1.2.4 MnM view
                                     15.1.2.4.1 Right to win
                                     15.1.2.4.2 Strategic choices
                                     15.1.2.4.3 Weaknesses & competitive threats
             15.1.3 SECTRA AB
                        15.1.3.1 Business overview
                        15.1.3.2 Solutions offered
                        15.1.3.3 MnM view
                                     15.1.3.3.1 Right to win
                                     15.1.3.3.2 Strategic choices
                                     15.1.3.3.3 Weaknesses & competitive threats
             15.1.4 GE HEALTHCARE TECHNOLOGIES INC.
                        15.1.4.1 Business overview
                        15.1.4.2 Solutions offered
                        15.1.4.3 Recent developments
                        15.1.4.4 MnM view
                                     15.1.4.4.1 Right to win
                                     15.1.4.4.2 Strategic choices
                                     15.1.4.4.3 Weaknesses & competitive threats
             15.1.5 MERATIVE
                        15.1.5.1 Business overview
                        15.1.5.2 Solutions offered
                        15.1.5.3 Recent developments
                        15.1.5.4 MnM view
                                     15.1.5.4.1 Key strengths
                                     15.1.5.4.2 Strategic choices
                                     15.1.5.4.3 Weaknesses & competitive threats
             15.1.6 KONINKLIJKE PHILIPS N.V.
                        15.1.6.1 Business overview
                        15.1.6.2 Solutions offered
                        15.1.6.3 Recent developments
             15.1.7 CANON MEDICAL SYSTEMS CORPORATION
                        15.1.7.1 Business overview
                        15.1.7.2 Solutions offered
                        15.1.7.3 Recent developments
             15.1.8 INTELERAD MEDICAL SYSTEMS INCORPORATED
                        15.1.8.1 Business overview
                        15.1.8.2 Solutions offered
                        15.1.8.3 Recent developments
             15.1.9 PAXERAHEALTH
                        15.1.9.1 Business overview
                        15.1.9.2 Solutions offered
             15.1.10 NOVARAD CORPORATION
                        15.1.10.1 Business overview
                        15.1.10.2 Solutions offered
             15.1.11 HYLAND SOFTWARE, INC.
                        15.1.11.1 Business overview
                        15.1.11.2 Solutions offered
                        15.1.11.3 Recent developments
             15.1.12 SIEMENS HEALTHCARE LIMITED
                        15.1.12.1 Business overview
                        15.1.12.2 Solutions offered
             15.1.13 BRIDGEHEAD SOFTWARE LTD.
                        15.1.13.1 Business overview
                        15.1.13.2 Solutions offered
                        15.1.13.3 Recent developments
             15.1.14 CANOPY PARTNERS
                        15.1.14.1 Business overview
                        15.1.14.2 Solutions offered
             15.1.15 CRELIOHEALTH INC.
                        15.1.15.1 Business overview
                        15.1.15.2 Solutions offered
             15.1.16 ASPYRA, LLC
                        15.1.16.1 Business overview
                        15.1.16.2 Solutions offered
             15.1.17 POSTDICOM
                        15.1.17.1 Business overview
                        15.1.17.2 Solutions offered
             15.1.18 MEDICASOFT
                        15.1.18.1 Business overview
                        15.1.18.2 Solutions offered
             15.1.19 ESAOTE SPA
                        15.1.19.1 Business overview
                        15.1.19.2 Solutions offered
             15.1.20 VISUS HEALTH IT GMBH
                        15.1.20.1 Business overview
                        15.1.20.2 Solutions offered
     15.2 OTHER PLAYERS 
             15.2.1 ADVAHEALTH SOLUTIONS
             15.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
             15.2.3 ARO SYSTEMS
             15.2.4 CENTRAL DATA NETWORKS
             15.2.5 ONEPACS
             15.2.6 DEDALUS S.P.A.
 
16 APPENDIX (Page No. - 397)
     16.1 DISCUSSION GUIDE 
     16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     16.3 CUSTOMIZATION OPTIONS 
     16.4 RELATED REPORTS 
     16.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (522 TABLES)
 
TABLE 1 FACTOR ANALYSIS
TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH)
TABLE 3 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 4 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
TABLE 5 IMPACT OF PORTER’S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
TABLE 6 LIST OF CONFERENCES & EVENTS, 2024–2025
TABLE 7 AVERAGE SELLING PRICE OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: UNMET NEEDS
TABLE 15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END-USER EXPECTATIONS
TABLE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 18 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 19 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 20 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 21 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 22 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 23 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 24 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 25 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 26 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 27 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 28 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 29 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 32 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 33 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 34 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 35 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 36 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 37 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 38 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 41 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 44 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 45 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 46 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 47 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 48 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 49 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 54 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 55 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 56 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 57 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 58 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 59 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 60 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 61 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 62 INDEPENDENT VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
TABLE 63 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 64 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 65 THIRD-PARTY VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
TABLE 66 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 67 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 68 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 69 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 70 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 71 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 72 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 73 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 74 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 75 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 76 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 77 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 78 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 79 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 80 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 81 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 82 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 83 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 84 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 85 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 86 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 87 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 88 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 89 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 90 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 91 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 92 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 93 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 95 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 97 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 98 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 99 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 101 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 103 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 105 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 106 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 107 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 108 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 109 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 110 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 111 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 112 US: KEY MACRO INDICATORS
TABLE 113 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 114 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 115 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 116 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 117 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 118 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 119 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 120 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 121 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 122 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 123 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 124 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 125 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 126 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 127 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 128 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 129 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 130 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 131 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 132 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 133 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 134 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 135 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 136 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 137 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 138 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 139 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 140 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 141 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 142 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 143 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 144 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 145 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 146 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 147 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 148 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 149 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 150 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 151 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 152 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 153 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 154 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 155 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 156 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 157 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 158 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 159 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 160 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 161 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 162 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 163 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 164 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 165 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 166 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 167 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 168 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 169 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 170 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 171 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 172 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 173 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 174 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 175 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 176 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 177 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 178 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 179 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 180 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 181 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 182 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE 2023–2029 (USD MILLION)
TABLE 183 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 184 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 185 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 186 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 187 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 188 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 189 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 190 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 191 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 192 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 193 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 194 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 195 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 196 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 197 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 198 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 199 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 200 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 201 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 202 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 203 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 204 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 205 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 206 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 207 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 208 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 209 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 210 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 211 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 212 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 213 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 214 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 215 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 216 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 217 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 218 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 219 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 220 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 221 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 222 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 223 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 224 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 225 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 226 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 227 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 228 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 229 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 230 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 231 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 232 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 233 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 234 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 235 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 236 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 237 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 238 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 239 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 240 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 241 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 242 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 243 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 244 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 245 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 246 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 247 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 248 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 249 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 250 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY MODALITY, 2023–2029 (USD MILLION)
TABLE 251 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 252 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 253 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 254 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 255 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 256 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 257 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 258 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 260 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 261 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 262 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 263 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 264 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 265 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 266 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 267 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 268 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 269 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 270 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 271 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 272 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 274 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 276 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 277 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 278 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 279 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 280 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 281 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 282 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 283 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 284 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 285 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 286 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 287 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 288 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 289 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 290 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 291 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 292 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 293 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 294 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 295 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 296 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 297 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 298 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 299 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 300 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 301 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 302 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 303 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 304 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 305 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 306 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 307 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 308 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 309 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 310 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 311 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 312 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 313 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 314 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 315 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 316 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 317 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 318 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 319 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 320 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 321 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 322 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 323 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 324 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 335 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 336 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 337 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 338 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 339 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 340 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 341 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018–2022 (USD MILLION)
TABLE 342 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023–2029 (USD MILLION)
TABLE 343 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 344 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 345 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 346 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 347 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 348 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 349 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 350 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 351 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 352 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 353 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 354 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 355 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 356 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 357 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 358 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 359 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 360 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 361 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 362 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 363 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 364 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023–2029 (USD MILLION)
TABLE 365 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 366 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 367 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 368 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 369 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 370 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 371 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 372 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 373 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 374 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 375 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 376 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 377 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 378 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 379 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 380 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 381 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 382 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 383 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 384 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 385 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 386 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 387 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 388 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 389 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 390 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 391 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 393 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 394 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 395 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 396 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 397 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 398 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 399 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 400 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 401 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 402 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 403 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 404 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 405 REST OF LATINA AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 407 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018–2022 (USD MILLION)
TABLE 408 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 409 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 410 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,  BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 411 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 412 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 421 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 422 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 423 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 424 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 425 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 426 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 427 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 428 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 429 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 430 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 431 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 432 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 433 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 434 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 435 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 436 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 437 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 438 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 439 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 440 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018–2022 (USD MILLION)
TABLE 446 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023–2029 (USD MILLION)
TABLE 447 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
TABLE 448 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
TABLE 449 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION)
TABLE 450 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION)
TABLE 451 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018–2022 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023–2029 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018–2022 (USD MILLION)
TABLE 454 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)
TABLE 455 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018–2022 (USD MILLION)
TABLE 456 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023–2029 (USD MILLION)
TABLE 457 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION
TABLE 458 OVERALL COMPANY FOOTPRINT
TABLE 459 PRODUCT TYPE FOOTPRINT
TABLE 460 DEPLOYMENT FOOTPRINT
TABLE 461 END USER FOOTPRINT
TABLE 462 REGIONAL FOOTPRINT (19 COMPANIES)
TABLE 463 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 464 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 465 PRODUCT LAUNCHES & UPGRADES, AUGUST 2021–NOVEMBER 2023
TABLE 466 DEALS, JANUARY 2023–MARCH 2024
TABLE 467 OTHER DEVELOPMENTS, NOVEMBER 2022–NOVEMBER 2024
TABLE 468 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW
TABLE 469 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
TABLE 470 AGFA-GEVAERT GROUP: DEALS, JANUARY 2020–APRIL 2024
TABLE 471 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 472 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
TABLE 473 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020–APRIL 2024
TABLE 474 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2024
TABLE 475 SECTRA AB: BUSINESS OVERVIEW
TABLE 476 SECTRA AB: SOLUTIONS OFFERED
TABLE 477 GE HEALTHCARE TECHNOLOGIES INC.: BUSINESS OVERVIEW
TABLE 478 GE HEALTHCARE TECHNOLOGIES INC.: SOLUTIONS OFFERED
TABLE 479 GE HEALTHCARE TECHNOLOGIES INC.: PRODUCTS LAUNCHES, JANUARY 2020–APRIL 2024
TABLE 480 MERATIVE: BUSINESS OVERVIEW
TABLE 481 MERATIVE: SOLUTIONS OFFERED
TABLE 482 MERATIVE: DEALS, NOVEMBER 2023
TABLE 483 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 484 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
TABLE 485 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2024
TABLE 486 KONINKLIJKE PHILIPS N.V.: DEALS, APRIL 2023
TABLE 487 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 488 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
TABLE 489 CANON MEDICAL SYSTEMS CORPORATION: DEALS, NOVEMBER 203
TABLE 490 CANON MEDICAL SYSTEMS CORPORATION: OTHER DEVELOPMENTS, NOVEMBER 2022
TABLE 491 INTELERAD MEDICAL SYSTEMS INCORPORATED: BUSINESS OVERVIEW
TABLE 492 INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTIONS OFFERED
TABLE 493 INTELERAD MEDICAL SYSTEMS INCORPORATED: DEALS, DECEMBER 2020–NOVEMBER 2023
TABLE 494 INTELERAD MEDICAL SYSTEMS INCORPORATED: OTHER DEVELOPMENTS, JULY 2021–NOVEMBER 2022
TABLE 495 PAXERAHEALTH: BUSINESS OVERVIEW
TABLE 496 PAXERAHEALTH: SOLUTIONS OFFERED
TABLE 497 NOVARAD CORPORATION: BUSINESS OVERVIEW
TABLE 498 NOVARAD CORPORATION: SOLUTIONS OFFERED
TABLE 499 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW
TABLE 500 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
TABLE 501 HYLAND SOFTWARE, INC.: PRODUCTS LAUNCHES & UPGRADES, DECEMBER 2020
TABLE 502 HYLAND SOFTWARE, INC.:DEALS, SEPTEMBER 2021–FEBRUARY 2024
TABLE 503 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW
TABLE 504 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED
TABLE 505 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW
TABLE 506 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
TABLE 507 BRIDGEHEAD SOFTWARE LTD.: PRODUCTS LAUNCHES & UPGRADES, MAY 2020
TABLE 508 BRIDGEHEAD SOFTWARE LTD.: DEALS, SEPTEMBER 2022
TABLE 509 CANOPY PARTNERS: BUSINESS OVERVIEW
TABLE 510 CANOPY PARTNERS: SOLUTIONS OFFERED
TABLE 511 CRELIOHEALTH INC.: BUSINESS OVERVIEW
TABLE 512 CRELIOHEALTH INC.: SOLUTIONS OFFERED
TABLE 513 ASPYRA, LLC: BUSINESS OVERVIEW
TABLE 514 ASPYRA, LLC: SOLUTIONS OFFERED
TABLE 515 POSTDICOM: BUSINESS OVERVIEW
TABLE 516 POSTDICOM: SOLUTIONS OFFERED
TABLE 517 MEDICASOFT: BUSINESS OVERVIEW
TABLE 518 MEDICASOFT: SOLUTIONS OFFERED
TABLE 519 ESAOTE SPA.: BUSINESS OVERVIEW
TABLE 520 ESAOTE SPA.: SOLUTIONS OFFERED
TABLE 521 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW
TABLE 522 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
 
 
LIST OF FIGURES (47 FIGURES)
 
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BOTTOM-UP APPROACH
FIGURE 7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: TOP-DOWN APPROACH
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 VNA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 CT SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029
FIGURE 13 CLOUD-BASED MODEL SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
FIGURE 14 INDEPENDENT VENDOR SEGMENT TO ACCOUNT FOR LARGER SHARE BY 2029
FIGURE 15 CARDIOLOGY SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
FIGURE 16 HOSPITALS & CLINICS SEGMENT TO LEAD MARKET IN 2024
FIGURE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHICAL SNAPSHOT
FIGURE 18 INCREASING VOLUME OF MEDICAL IMAGING DATA TO DRIVE MARKET
FIGURE 19 VNA SEGMENT AND JAPAN TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 21 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 23 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 REVENUE SHIFT IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS
FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING
FIGURE 27 GLOBAL PATENT PUBLICATION TRENDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2015–2024
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS (JANUARY 2015 TO APRIL 2024)
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
FIGURE 30 KEY BUYING CRITERIA FOR TOP END USERS
FIGURE 31 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
FIGURE 32 COUNT OF DIAGNOSTIC IMAGING ACTIVITY IN UK, ON NHS PATIENTS, FROM JANUARY 2022 TO JANUARY 2023
FIGURE 33 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
FIGURE 34 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 36 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2022)
FIGURE 37 EV/EBITDA OF KEY VENDORS
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
FIGURE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
FIGURE 41 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
FIGURE 43 SECTRA AB: COMPANY SNAPSHOT
FIGURE 44 GE HEALTHCARE TECHNOLOGIES INC.: COMPANY SNAPSHOT
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 46 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
FIGURE 47 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT

The study involved five major activities to estimate the current size of the Vendor Neutral Archive (VNA) & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of Vendor Neutral Archive (VNA) & PACS Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Vendor Neutral Archive (VNA) & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Vendor Neutral Archive (VNA) & PACS  Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Vendor Neutral Archive (VNA) & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Vendor Neutral Archive (VNA) & PACS Market Size: Bottom-Up Approach

Vendor Neutral Archive (VNA) & PACS  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vendor Neutral Archive (VNA) & PACS Market Size: Top-Down Approach

Vendor Neutral Archive (VNA) & PACS  Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Vendor Neutral Archive (VNA) & PACS Market.

Market Definition:

Vendor Neutral Archive (VNA) & PACS market refers to medical imaging technology that provides economical storage and convenient access to images from multiple modalities designed to store, manage, and access medical imaging data efficiently and securely. VNAs and PACS solutions serve as integral components of modern healthcare IT infrastructure, facilitating the digitization, storage, retrieval, and sharing of medical images.

Key Stakeholders:

  • Vendor Neutral Archive (VNA) & PACS Vendors
  • Government Bodies
  • Healthcare Service Providers
  • Clinical/Physician Centers
  • Healthcare Professionals
  • Health IT service Providers
  • Healthcare Associations/Institutes
  • Ambulatory Care Centers
  • Venture Capitalists
  • Distributors And Resellers
  • Maintenance And Support Service Providers
  • Integration Service Providers
  • Healthcare Payers
  • Advocacy Groups
  • Data Security And Privacy Experts
  • Investors And Financial Institutions
  • Industry Associations And Trade Groups

Report Objectives

  • To define, describe, and forecast the global Vendor Neutral Archive (VNA) & PACS market based on product type, modality, deployment, vendor type, application, end user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall Vendor Neutral Archive (VNA) & PACS market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile the key players of the Vendor Neutral Archive (VNA) & PACS market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in the Vendor Neutral Archive (VNA) & PACS market during the forecast period.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis: Further breakdown of the Latin American Vendor Neutral Archive (VNA) & PACS into specific countries and, the Middle East, and Africa Vendor Neutral Archive (VNA) & PACS into specific countries and further breakdown of the European Vendor Neutral Archive (VNA) & PACS into specific countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 2128
Published ON
May, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback